Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects
Diabetes Mellitus, Inflammation
About this trial
This is an interventional basic science trial for Diabetes Mellitus focused on measuring egg, oatmeal, atherogenic dyslipidemia, glycosylated hemoglobin, inflammatory markers
Eligibility Criteria
Inclusion Criteria:
- diabetic subjects diagnosed by physician
- male and female
- 35-65 years
- Glycosylated hemoglobin < 9%
Exclusion Criteria:
- taking ezetimibe
- heart disease
- renal problems
- cancer
- thyroid problems
Sites / Locations
- Centro de Investigacion y Desarrollo
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Egg, one a day, for breakfast
Oatmeal, one cup a day
The intervention consists in feeding the subjects egg, one a day for breakfast during 5 weeks. At the end of the intervention, blood will be obtained to measure plasma lipids, glucose, insulin and inflammatory markers. All measurements will be finished 24 weeks after the intervention is finished. All data will be reported 1 year after completion of the study.
In this arm, subjects will consume oatmeal for a period of 5 weeks. Blood samples will be taken and different parameters will be measured including plasma lipids, glucose, insulin and inflammatory markers. All these measurements will be finished 24 weeks after completion of the study. All data will be reported 1 year after completion of the study.